Although the cytoprotective system is designed to prevent normal cells from becoming cancerous, in a cisplatin-induced ROS-rich environment, cancer cells may hijack the Keap1/Nrf2 system and induce AKR1C2 protein expression as an antioxidant substance. This evidence concerns the gene NFE2L2 and cancer.